Hikma And Richter Move Ahead With US Denosumab Filing
Marks Entry Of Hikma Into US Biosimilars Arena
Hikma has marked a major step forward in US biosimilars by filing with the US Food and Drug Administration its Gedeon Richter-partnered denosumab rival to Prolia and Xgeva.
